Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1452-1467

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet   Kanoje Vijay   Semwal Arvind   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Phospholipase A₂ inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

By Magrioti Victoria   Kokotos George  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite

The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 85-97

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis

By Mbalaviele Gabriel   Monahan Joseph B  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite